Most Read This Week
- Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination–Related Genes
- Osimertinib vs First-Generation EGFR-TKIs in EGFR-Mutant Advanced NSCLC Without Baseline CNS Metastasis
- Covid-19 — Navigating the Uncharted
- Internal Mammary and Medial Supraclavicular Lymph Node Chain Irradiation in Stage I–III Breast Cancer
- Efficacy of CTC Count–Driven vs Clinician-Driven First-Line Therapy Choice in HR+, ERBB2− Metastatic Breast Cancer
Recently Updated
- Predictors of Late Effects in Young AML Survivors Explored
- Less Than One in 20 Eligible Adults Receives Lung Cancer Screening
- ALA: Lung Cancer Survival Has Increased Nationally to 22.6 Percent
- Biopsy Reclassification Risk in Prostate Cancer Examined
- Rates of VTE, Major Bleeding High in Primary CNS Lymphoma